{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T23:59:48Z","timestamp":1770767988613,"version":"3.50.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NCI"},{"name":"Kaiser Permanente Northern California"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ypmed.2017.12.023","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T18:00:01Z","timestamp":1514397601000},"page":"44-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7761-8728","authenticated-orcid":false,"given":"Katharine A.","family":"Rendle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li C.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter K.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Fetterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Poitras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ypmed.2017.12.023_bb0005","first-page":"417","article-title":"ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995)","volume":"102","author":"ACOG Committee on Practice Bulletins","year":"2003","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ypmed.2017.12.023_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ypmed.2004.05.003","article-title":"Correlates of cervical cancer screening among underserved Hispanic and African-American women","volume":"39","author":"Bazargan","year":"2004","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2017.12.023_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.30507","article-title":"Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States","author":"Beavis","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ypmed.2017.12.023_bb0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/jwh.2015.5326","article-title":"Discontent and confusion: primary care providers' opinions and understanding of current cervical cancer screening recommendations","volume":"25","author":"Boone","year":"2016","journal-title":"J. Women's Health (Larchmt)"},{"key":"10.1016\/j.ypmed.2017.12.023_bb0025","article-title":"Latina and Black\/African American women's perspectives on cancer screening and cancer screening reminders","author":"Brandzel","year":"2016","journal-title":"J. Racial Ethn. Health Disparities"},{"issue":"3","key":"10.1016\/j.ypmed.2017.12.023_bb0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181996ffa","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"51\u201352","key":"10.1016\/j.ypmed.2017.12.023_bb0035","first-page":"1038","article-title":"Cervical cancer screening among women aged 18\u201330years - United States, 2000\u20132010","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2017.12.023_bb0040","author":"Collins"},{"issue":"5","key":"10.1016\/j.ypmed.2017.12.023_bb0045","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","article-title":"ACOG practice bulletin number 131: screening for cervical cancer","volume":"120","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2012","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ypmed.2017.12.023_bb0050","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.amepre.2015.04.025","article-title":"Acceptable and preferred cervical cancer screening intervals among U.S. women","volume":"49","author":"Cooper","year":"2015","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ypmed.2017.12.023_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ypmed.2017.12.023_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/LGT.0b013e31829325c3","article-title":"Cervical cancer rates after the transition from annual Pap to 3-year HPV and Pap","volume":"18","author":"Dinkelspiel","year":"2014","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"8","key":"10.1016\/j.ypmed.2017.12.023_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ypmed.2017.12.023_bb0070","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ijc.30524","article-title":"Harms of cervical cancer screening in the United States and the Netherlands","volume":"140","author":"Habbema","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2017.12.023_bb0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ypmed.2016.05.017","article-title":"The influence of marital status on the use of breast, cervical, and colorectal cancer screening","volume":"89","author":"Hanske","year":"2016","journal-title":"Prev. Med."},{"issue":"5","key":"10.1016\/j.ypmed.2017.12.023_bb0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ypmed.2013.08.021","article-title":"Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers","volume":"57","author":"Hawkins","year":"2013","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2017.12.023_bb0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ypmed.2014.02.004","article-title":"U.S. clinicians' perspectives on less frequent routine gynecologic examinations","volume":"62","author":"Henderson","year":"2014","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2017.12.023_bb0090","series-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100B","author":"IARC Working Group on the Evaluation of Carcinogenic Risk to Humans","year":"2012"},{"issue":"7","key":"10.1016\/j.ypmed.2017.12.023_bb0095","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ypmed.2017.12.023_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/AOG.0000000000000632","article-title":"Increased cervical cancer risk associated with screening at longer intervals","volume":"125","author":"Kinney","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2017.12.023_bb0105","article-title":"Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia","volume":"9","author":"Kyrgiou","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.ypmed.2017.12.023_bb0110","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jamia\/ocv156","article-title":"Assessing race and ethnicity data quality across cancer registries and EMRs in two hospitals","volume":"23","author":"Lee","year":"2016","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"3","key":"10.1016\/j.ypmed.2017.12.023_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MLR.0b013e3181ca4015","article-title":"Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals","volume":"48","author":"Meissner","year":"2010","journal-title":"Med. Care"},{"issue":"12","key":"10.1016\/j.ypmed.2017.12.023_bb0120","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2017.12.023_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.annepidem.2015.10.004","article-title":"Disparities in cervical cancer survival among Asian-American women","volume":"26","author":"Nghiem","year":"2016","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.ypmed.2017.12.023_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-016-2865-8","article-title":"Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval","volume":"16","author":"Ogilvie","year":"2016","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.ypmed.2017.12.023_bb0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1037\/0033-2909.124.1.54","article-title":"Habit and intention in everyday life: the multiple processes by which past behavior predicts future behavior","volume":"124","author":"Ouellette","year":"1998","journal-title":"Psychol. Bull."},{"issue":"1","key":"10.1016\/j.ypmed.2017.12.023_bb0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/AOG.0000000000001804","article-title":"Cervical cancer screening guideline adherence before and after guideline changes in Pennsylvania Medicaid","volume":"129","author":"Parekh","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ypmed.2017.12.023_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.amepre.2013.03.019","article-title":"Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists","volume":"45","author":"Perkins","year":"2013","journal-title":"Am. J. Prev. Med."},{"issue":"11","key":"10.1016\/j.ypmed.2017.12.023_bb0150","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.ypmed.2017.12.023_bb0155","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodr\u00edguez","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.ypmed.2017.12.023_bb0160","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1158\/1055-9965.EPI-12-1266","article-title":"Cervical cancer screening among young adult women in the United States","volume":"22","author":"Roland","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ypmed.2017.12.023_bb0165","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.pmedr.2015.05.008","article-title":"Provider beliefs associated with cervical cancer screening interval recommendations: a pilot study in Federally Qualified Health Centers","volume":"2","author":"Roland","year":"2015","journal-title":"Prev. Med. Rep."},{"issue":"2","key":"10.1016\/j.ypmed.2017.12.023_bb0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2150131915624869","article-title":"Changes in knowledge and beliefs about human papillomavirus and cervical cancer screening intervals in low-income women after an educational intervention","volume":"7","author":"Roland","year":"2016","journal-title":"J. Prim. Care Community Health"},{"issue":"9916","key":"10.1016\/j.ypmed.2017.12.023_bb0175","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ypmed.2017.12.023_bb0180","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guideline for the early detection of cervical neoplasia and cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ypmed.2017.12.023_bb0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ypmed.2017.12.023_bb0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0000000000000638","article-title":"Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening","volume":"125","author":"Silver","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ypmed.2017.12.023_bb0195","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1055-9965.EPI-14-0487","article-title":"Patient and provider characteristics associated with colorectal, breast, and cervical cancer screening among Asian Americans","volume":"23","author":"Thompson","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"8","key":"10.1016\/j.ypmed.2017.12.023_bb0200","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10552-016-0776-8","article-title":"Determinants of cancer screening in Asian-Americans","volume":"27","author":"Trinh","year":"2016","journal-title":"Cancer Causes Control"},{"issue":"8","key":"10.1016\/j.ypmed.2017.12.023_bb0205","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1158\/1055-9965.EPI-08-0078","article-title":"Disparities in cervical cancer screening between Asian American and non-Hispanic white women","volume":"17","author":"Wang","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174351730511X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174351730511X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T16:41:56Z","timestamp":1620837716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009174351730511X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":41,"alternative-id":["S009174351730511X"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2017.12.023","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2017.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}